microRNAs‐based diagnostic and therapeutic applications in liver fibrosis

Abstract Liver fibrosis is a process of over‐extracellular matrix (ECM) aggregation and angiogenesis, which develops into cirrhosis and hepatocellular carcinoma (HCC). With the increasing pressure of liver fibrosis, new therapeutics to cure this disease requires much attention. Exosome‐cargoed microRNAs (miRNAs) are emerging approaches in the precision of the liver fibrotic paradigm. In this review, we outlined the different types of hepatic cells derived miRNAs that drive intra‐/extra‐cellular interactive communication in liver fibrosis with different physiological and pathological processes. Specifically, we highlighted the possible mechanism of liver fibrosis pathogenesis associated with immune response and angiogenesis. In addition, potential clinical biomarkers and different stem cell transplant‐derived miRNAs‐based therapeutic strategies in liver fibrosis were summarized in this review. miRNAs‐based approaches might help researchers devise new candidates for the cell‐free treatment of liver fibrosis. This article is categorized under: RNA in Disease and Development > RNA in Disease